Next Generation Sequencing Market Analysis By Application (HLA Testing, Prenatal Testing, Oncology, Idiopathic & Infectious Diseases), By Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis) And Segment Forecasts To 2022
The global market for next generation sequencing is expected to reach USD 27.87 billion by 2022. Technological developments in the field of genomic sequencing is expected to cause a decline in the cost of sequencing per base pair and thereby, greatly enhance adoption and usage rates of next generation sequencing over the forecast period. With this expected increase in usage of whole genome sequencing, a consequent increase in revenue from HLA and prenatal testing segments is also expected, owing to the introduction of more informative novel phase resolved single cycle reads. Growing incidences of cancer and infectious diseases are further expected to fuel the growth of the next generation sequencing market over the forecast period.
Further key findings from the study suggest:
Targeted sequencing & resequencing was the leading technology segment of the market in 2014, majorly owing to rapidly growing demand in oncology and infectious diseases related research. Sequencing of targeted genes allows researchers to gain insights into the functioning of cancer cells and pathogenic life cycles. Growing incidences of life threatening forms of cancer and infectious diseases is a high impact rendering factor expected to contribute to the growth of this segment over the forecast period.
The next generation sequencing based oncology market is expected to lead the market in terms of revenue throughout the forecast period. However, the use of NGS in fields of HLA and prenatal testing are expected to grow at a relatively higher rate through to 2022, owing to the introduction of techniques which can enable researchers to acquire phase-resolved HLA and prenatal sequences in single cycle reads. In addition, recent developments are expected to solve sequencing ambiguity issues and provide greater insights about genetic functioning.
Next generation sequencing was the largest workflow segment of the market in 2014. The introduction of technologically advanced genome sequencing platforms and the growing demand for personalized medicine are two factors likely to drive segment growth over the forecast period.
Next generation sequencing based data analysis is also expected to grow at a considerably high rate during the forecast period. Large amounts of sequencing data generated from extensive R&D initiatives and the subsequent growth in demand for storage and analysis are some factors attributing to the segment’s rapid growth.
North America emerged as the leading regional market in 2014. High R&D investment directed towards the development of genome sequencing, presence of sophisticated technology framework, increasing adoption rates of whole genome sequencing and the reduction in cost of sequencing per base pair are some factors accounting for the region’s large market share.
Key participants of the next generation sequencing market include GATC Biotech AG., Life Technologies (Thermo Fisher Scientific), 454 Life Sciences Corp. (Roche Holding AG), Pacific Biosciences, Agilent Technologies Inc., Macrogen Inc., Beijing Genomics Institute, Biomatters Ltd., CLC bio (Qiagen), Illumina Inc., DNASTAR Inc., Knome Inc., Qiagen NV., Helicos BioSciences, and Oxford Nanopore Technologies.
For the purpose of this study, Grand View Research has segmented the next generation sequencing market on the basis of technology, workflow, application and region:
Global Next Generation Sequencing Application Outlook (Revenue, USD Billion, 2012 – 2022)
Further key findings from the study suggest:
Targeted sequencing & resequencing was the leading technology segment of the market in 2014, majorly owing to rapidly growing demand in oncology and infectious diseases related research. Sequencing of targeted genes allows researchers to gain insights into the functioning of cancer cells and pathogenic life cycles. Growing incidences of life threatening forms of cancer and infectious diseases is a high impact rendering factor expected to contribute to the growth of this segment over the forecast period.
The next generation sequencing based oncology market is expected to lead the market in terms of revenue throughout the forecast period. However, the use of NGS in fields of HLA and prenatal testing are expected to grow at a relatively higher rate through to 2022, owing to the introduction of techniques which can enable researchers to acquire phase-resolved HLA and prenatal sequences in single cycle reads. In addition, recent developments are expected to solve sequencing ambiguity issues and provide greater insights about genetic functioning.
Next generation sequencing was the largest workflow segment of the market in 2014. The introduction of technologically advanced genome sequencing platforms and the growing demand for personalized medicine are two factors likely to drive segment growth over the forecast period.
Next generation sequencing based data analysis is also expected to grow at a considerably high rate during the forecast period. Large amounts of sequencing data generated from extensive R&D initiatives and the subsequent growth in demand for storage and analysis are some factors attributing to the segment’s rapid growth.
North America emerged as the leading regional market in 2014. High R&D investment directed towards the development of genome sequencing, presence of sophisticated technology framework, increasing adoption rates of whole genome sequencing and the reduction in cost of sequencing per base pair are some factors accounting for the region’s large market share.
Key participants of the next generation sequencing market include GATC Biotech AG., Life Technologies (Thermo Fisher Scientific), 454 Life Sciences Corp. (Roche Holding AG), Pacific Biosciences, Agilent Technologies Inc., Macrogen Inc., Beijing Genomics Institute, Biomatters Ltd., CLC bio (Qiagen), Illumina Inc., DNASTAR Inc., Knome Inc., Qiagen NV., Helicos BioSciences, and Oxford Nanopore Technologies.
For the purpose of this study, Grand View Research has segmented the next generation sequencing market on the basis of technology, workflow, application and region:
Global Next Generation Sequencing Application Outlook (Revenue, USD Billion, 2012 – 2022)
- HLA Testing
- Prenatal Testing
- Oncology
- Idiopathic Diseases
- Infectious Diseases
- Others
- Whole Genome Sequencing
- Whole Exon Sequencing
- Targeted Sequencing & Resequencing
- NGS Pre-sequencing
- NGS Sequencing
- NGS Data Analysis
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- MEA
- South Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Next Generation Sequencing – Industry Snapshot and Key Buying Criteria, 2012 - 2022
CHAPTER 2. NEXT GENERATION SEQUENCING INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Next Generation Sequencing Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Industry Analysis - Porter's
2.5. Key Opportunities Prioritized & Platform Positioning
2.5.1. Key Opportunities Prioritized
2.5.2. NGS Platform Positioning
2.6. Next Generation Sequencing Market PESTEL Analysis, 2014
2.7. Company Market Share Analysis, 2014
2.8. Product and competitive landscape analysis
2.8.1. Penetration levels
2.8.2. Comparative analysis
2.8.3. Application areas
CHAPTER 3. NEXT GENERATION SEQUENCING APPLICATION OUTLOOK
3.1. HLA Testing
3.1.1. HLA Testing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.2. Prenatal Testing
3.2.1. Prenatal Testing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.3. Oncology
3.3.1. Oncology Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.4. Idiopathic Diseases
3.4.1. Idiopathic Diseases Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.5. Infectious Diseases
3.5.1. Infectious Diseases Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
CHAPTER 4. NEXT GENERATION SEQUENCING TECHNOLOGY OUTLOOK
4.1. Whole Genome Sequencing
4.1.1. Whole Genome Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
4.2. Whole Exon Sequencing
4.2.1. Whole Exon Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
4.3. Targeted Sequencing & Resequencing
4.3.1. Targeted Sequencing & Resequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
CHAPTER 5. NEXT GENERATION SEQUENCING WORKFLOW OUTLOOK
5.1. NGS Pre-sequencing
5.1.1. NGS Pre-sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
5.2. NGS Sequencing
5.2.1. NGS Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
5.3. NGS Data Analysis
5.3.1. NGS Data Analysis Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
CHAPTER 6. NEXT GENERATION SEQUENCING REGIONAL OUTLOOK
6.1. North America
6.1.1. U.S.
6.1.1.1. U.S. Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.1.1.2. U.S. Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.1.1.3. U.S. Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.1.2. Canada
6.1.2.1. Canada Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.1.2.2. Canada Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.1.2.3. Canada Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.2. Europe
6.2.1. Germany
6.2.1.1. Germany Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.2.1.2. Germany Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.2.1.3. Germany Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.2.2. UK
6.2.2.1. UK Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.2.2.2. UK Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.2.2.3. UK Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.3. Asia Pacific
6.3.1. Japan
6.3.1.1. Japan Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.3.1.2. Japan Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.3.1.3. Japan Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.3.2. China
6.3.2.1. China Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.3.2.2. China Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.3.2.3. China Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.4. Latin America
6.4.1. Brazil
6.4.1.1. Brazil Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.4.1.2. Brazil Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.4.1.3. Brazil Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.5. MEA
6.5.1. South Africa
6.5.1.1. South Africa Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.5.1.2. South Africa Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.5.1.3. South Africa Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Illumina, Inc.
7.1.1. Company Overview
7.1.2. Revenue Analysis
7.1.3. Product Benchmarking
7.1.4. Strategic Development
7.2. 454 Life Sciences Corporation (Roche Holding Ag)
7.2.1. Company Overview
7.2.2. Revenue Analysis
7.2.3. Product Benchmarking
7.2.4. Strategic Development
7.3. Agilent Technologies, Inc.
7.3.1. Company Overview
7.3.2. Revenue Analysis
7.3.3. Product Benchmarking
7.3.4. Strategic Development
7.4. BGI (Beijing Genomics Institute)
7.4.1. Company Overview
7.4.2. Revenue Analysis
7.4.3. Product Benchmarking
7.4.4. Strategic Development
7.5. Biomatters, Ltd.
7.5.1. Company Overview
7.5.2. Revenue Analysis
7.5.3. Product Benchmarking
7.5.4. Strategic Development
7.6. CLC bio (Acquired By Qiagen)
7.6.1. Company Overview
7.6.2. Revenue Analysis
7.6.3. Product Benchmarking
7.6.4. Strategic Development
7.7. DNASTAR, Inc.
7.7.1. Company Overview
7.7.2. Revenue Analysis
7.7.3. Product Benchmarking
7.7.4. Strategic Development
7.8. GATC Biotech Ag
7.8.1. Company Overview
7.8.2. Revenue Analysis
7.8.3. Product Benchmarking
7.8.4. Strategic Development
7.9. Genomatix Software GmbH
7.9.1. Company Overview
7.9.2. Revenue Analysis
7.9.3. Product Benchmarking
7.9.4. Strategic Development
7.10. Knome, Inc.
7.10.1. Company Overview
7.10.2. Revenue Analysis
7.10.3. Product Benchmarking
7.10.4. Strategic Development
7.11. Life Technologies Corporation (Thermo Fisher Scientific)
7.11.1. Company Overview
7.11.2. Revenue Analysis
7.11.3. Product Benchmarking
7.11.4. Strategic Development
7.12. Macrogen, Inc.
7.12.1. Company Overview
7.12.2. Revenue Analysis
7.12.3. Product Benchmarking
7.12.4. Strategic Development
7.13. Oxford Nanopore Technologies, Ltd.
7.13.1. Company Overview
7.13.2. Revenue Analysis
7.13.3. Product Benchmarking
7.13.4. Strategic Development
7.14. Pacific Biosciences
7.14.1. Company Overview
7.14.2. Revenue Analysis
7.14.3. Product Benchmarking
7.14.4. Strategic Development
7.15. Partek Incorporated
7.15.1. Company Overview
7.15.2. Revenue Analysis
7.15.3. Product Benchmarking
7.15.4. Strategic Development
7.16. Perkin Elmer, Inc.
7.16.1. Company Overview
7.16.2. Revenue Analysis
7.16.3. Product Benchmarking
7.16.4. Strategic Development
7.17. Qiagen N.V.
7.17.1. Company Overview
7.17.2. Revenue Analysis
7.17.3. Product Benchmarking
7.17.4. Strategic Development
1.1. Next Generation Sequencing – Industry Snapshot and Key Buying Criteria, 2012 - 2022
CHAPTER 2. NEXT GENERATION SEQUENCING INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Next Generation Sequencing Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Industry Analysis - Porter's
2.5. Key Opportunities Prioritized & Platform Positioning
2.5.1. Key Opportunities Prioritized
2.5.2. NGS Platform Positioning
2.6. Next Generation Sequencing Market PESTEL Analysis, 2014
2.7. Company Market Share Analysis, 2014
2.8. Product and competitive landscape analysis
2.8.1. Penetration levels
2.8.2. Comparative analysis
2.8.3. Application areas
CHAPTER 3. NEXT GENERATION SEQUENCING APPLICATION OUTLOOK
3.1. HLA Testing
3.1.1. HLA Testing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.2. Prenatal Testing
3.2.1. Prenatal Testing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.3. Oncology
3.3.1. Oncology Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.4. Idiopathic Diseases
3.4.1. Idiopathic Diseases Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.5. Infectious Diseases
3.5.1. Infectious Diseases Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
CHAPTER 4. NEXT GENERATION SEQUENCING TECHNOLOGY OUTLOOK
4.1. Whole Genome Sequencing
4.1.1. Whole Genome Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
4.2. Whole Exon Sequencing
4.2.1. Whole Exon Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
4.3. Targeted Sequencing & Resequencing
4.3.1. Targeted Sequencing & Resequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
CHAPTER 5. NEXT GENERATION SEQUENCING WORKFLOW OUTLOOK
5.1. NGS Pre-sequencing
5.1.1. NGS Pre-sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
5.2. NGS Sequencing
5.2.1. NGS Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
5.3. NGS Data Analysis
5.3.1. NGS Data Analysis Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
CHAPTER 6. NEXT GENERATION SEQUENCING REGIONAL OUTLOOK
6.1. North America
6.1.1. U.S.
6.1.1.1. U.S. Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.1.1.2. U.S. Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.1.1.3. U.S. Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.1.2. Canada
6.1.2.1. Canada Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.1.2.2. Canada Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.1.2.3. Canada Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.2. Europe
6.2.1. Germany
6.2.1.1. Germany Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.2.1.2. Germany Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.2.1.3. Germany Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.2.2. UK
6.2.2.1. UK Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.2.2.2. UK Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.2.2.3. UK Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.3. Asia Pacific
6.3.1. Japan
6.3.1.1. Japan Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.3.1.2. Japan Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.3.1.3. Japan Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.3.2. China
6.3.2.1. China Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.3.2.2. China Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.3.2.3. China Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.4. Latin America
6.4.1. Brazil
6.4.1.1. Brazil Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.4.1.2. Brazil Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.4.1.3. Brazil Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.5. MEA
6.5.1. South Africa
6.5.1.1. South Africa Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.5.1.2. South Africa Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.5.1.3. South Africa Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Illumina, Inc.
7.1.1. Company Overview
7.1.2. Revenue Analysis
7.1.3. Product Benchmarking
7.1.4. Strategic Development
7.2. 454 Life Sciences Corporation (Roche Holding Ag)
7.2.1. Company Overview
7.2.2. Revenue Analysis
7.2.3. Product Benchmarking
7.2.4. Strategic Development
7.3. Agilent Technologies, Inc.
7.3.1. Company Overview
7.3.2. Revenue Analysis
7.3.3. Product Benchmarking
7.3.4. Strategic Development
7.4. BGI (Beijing Genomics Institute)
7.4.1. Company Overview
7.4.2. Revenue Analysis
7.4.3. Product Benchmarking
7.4.4. Strategic Development
7.5. Biomatters, Ltd.
7.5.1. Company Overview
7.5.2. Revenue Analysis
7.5.3. Product Benchmarking
7.5.4. Strategic Development
7.6. CLC bio (Acquired By Qiagen)
7.6.1. Company Overview
7.6.2. Revenue Analysis
7.6.3. Product Benchmarking
7.6.4. Strategic Development
7.7. DNASTAR, Inc.
7.7.1. Company Overview
7.7.2. Revenue Analysis
7.7.3. Product Benchmarking
7.7.4. Strategic Development
7.8. GATC Biotech Ag
7.8.1. Company Overview
7.8.2. Revenue Analysis
7.8.3. Product Benchmarking
7.8.4. Strategic Development
7.9. Genomatix Software GmbH
7.9.1. Company Overview
7.9.2. Revenue Analysis
7.9.3. Product Benchmarking
7.9.4. Strategic Development
7.10. Knome, Inc.
7.10.1. Company Overview
7.10.2. Revenue Analysis
7.10.3. Product Benchmarking
7.10.4. Strategic Development
7.11. Life Technologies Corporation (Thermo Fisher Scientific)
7.11.1. Company Overview
7.11.2. Revenue Analysis
7.11.3. Product Benchmarking
7.11.4. Strategic Development
7.12. Macrogen, Inc.
7.12.1. Company Overview
7.12.2. Revenue Analysis
7.12.3. Product Benchmarking
7.12.4. Strategic Development
7.13. Oxford Nanopore Technologies, Ltd.
7.13.1. Company Overview
7.13.2. Revenue Analysis
7.13.3. Product Benchmarking
7.13.4. Strategic Development
7.14. Pacific Biosciences
7.14.1. Company Overview
7.14.2. Revenue Analysis
7.14.3. Product Benchmarking
7.14.4. Strategic Development
7.15. Partek Incorporated
7.15.1. Company Overview
7.15.2. Revenue Analysis
7.15.3. Product Benchmarking
7.15.4. Strategic Development
7.16. Perkin Elmer, Inc.
7.16.1. Company Overview
7.16.2. Revenue Analysis
7.16.3. Product Benchmarking
7.16.4. Strategic Development
7.17. Qiagen N.V.
7.17.1. Company Overview
7.17.2. Revenue Analysis
7.17.3. Product Benchmarking
7.17.4. Strategic Development
LIST OF TABLES
1. Next generation sequencing Market - Industry Summary & Key Buying Criteria
2. Next generation sequencing market, by application, 2012 - 2022 (USD Billion)
3. Next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
4. Next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
5. Next generation sequencing market, by region, 2012 - 2022 (USD Billion)
6. Next generation sequencing - Key market driver analysis
7. Next generation sequencing - Key market restraint analysis
8. Rating scale for platform positioning
9. North America market, by application, 2012 - 2022 (USD Billion)
10. North America market, by technology, 2012 - 2022 (USD Billion)
11. North America market, by workflow, 2012 - 2022 (USD Billion)
12. U.S. next generation sequencing market, by application, 2012 - 2022 (USD Billion)
13. U.S. next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
14. U.S. next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
15. Canada next generation sequencing market, by application, 2012 - 2022 (USD Billion)
16. Canada next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
17. Canada next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
18. Europe next generation sequencing market, by application, 2012 - 2022 (USD Billion)
19. Europe next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
20. Europe next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
21. Germany next generation sequencing market, by application, 2012 - 2022 (USD Billion)
22. Germany next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
23. Germany next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
24. UK next generation sequencing market, by application, 2012 - 2022 (USD Billion)
25. UK next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
26. UK next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
27. Asia Pacific market, by application, 2012 - 2022 (USD Billion)
28. Asia Pacific market, by technology, 2012 - 2022 (USD Billion)
29. Asia Pacific next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
30. Japan next generation sequencing market, by application, 2012 - 2022 (USD Billion)
31. Japan next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
32. Japan next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
33. China next generation sequencing market, by application, 2012 - 2022 (USD Billion)
34. China next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
35. China next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
36. Latin America market, by application, 2012 - 2022 (USD Billion)
37. Latin America market, by technology, 2012 - 2022 (USD Billion)
38. Latin America market, by workflow, 2012 - 2022 (USD Billion)
39. Brazil next generation sequencing market, by application, 2012 - 2022 (USD Billion)
40. Brazil next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
41. Brazil next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
42. MEA next generation sequencing market, by application, 2012 - 2022 (USD Billion)
43. MEA next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
44. MEA next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
45. South Africa market, by application, 2012 - 2022 (USD Billion)
46. South Africa market, by technology, 2012 - 2022 (USD Billion)
47. South Africa next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
1. Next generation sequencing Market - Industry Summary & Key Buying Criteria
2. Next generation sequencing market, by application, 2012 - 2022 (USD Billion)
3. Next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
4. Next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
5. Next generation sequencing market, by region, 2012 - 2022 (USD Billion)
6. Next generation sequencing - Key market driver analysis
7. Next generation sequencing - Key market restraint analysis
8. Rating scale for platform positioning
9. North America market, by application, 2012 - 2022 (USD Billion)
10. North America market, by technology, 2012 - 2022 (USD Billion)
11. North America market, by workflow, 2012 - 2022 (USD Billion)
12. U.S. next generation sequencing market, by application, 2012 - 2022 (USD Billion)
13. U.S. next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
14. U.S. next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
15. Canada next generation sequencing market, by application, 2012 - 2022 (USD Billion)
16. Canada next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
17. Canada next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
18. Europe next generation sequencing market, by application, 2012 - 2022 (USD Billion)
19. Europe next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
20. Europe next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
21. Germany next generation sequencing market, by application, 2012 - 2022 (USD Billion)
22. Germany next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
23. Germany next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
24. UK next generation sequencing market, by application, 2012 - 2022 (USD Billion)
25. UK next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
26. UK next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
27. Asia Pacific market, by application, 2012 - 2022 (USD Billion)
28. Asia Pacific market, by technology, 2012 - 2022 (USD Billion)
29. Asia Pacific next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
30. Japan next generation sequencing market, by application, 2012 - 2022 (USD Billion)
31. Japan next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
32. Japan next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
33. China next generation sequencing market, by application, 2012 - 2022 (USD Billion)
34. China next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
35. China next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
36. Latin America market, by application, 2012 - 2022 (USD Billion)
37. Latin America market, by technology, 2012 - 2022 (USD Billion)
38. Latin America market, by workflow, 2012 - 2022 (USD Billion)
39. Brazil next generation sequencing market, by application, 2012 - 2022 (USD Billion)
40. Brazil next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
41. Brazil next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
42. MEA next generation sequencing market, by application, 2012 - 2022 (USD Billion)
43. MEA next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
44. MEA next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
45. South Africa market, by application, 2012 - 2022 (USD Billion)
46. South Africa market, by technology, 2012 - 2022 (USD Billion)
47. South Africa next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
LIST OF FIGURES
1. Next Generation Sequencing: Market segmentation
2. Global next generation sequencing market, (USD Billion), 2012 - 2022
3. Next generation sequencing: Market dynamics
4. Next generation sequencing market - Porter’s Analysis
5. Key opportunities prioritized 2014
6. NGS Platform positioning
7. Next generation sequencing market - PESTEL analysis
8. Next generation sequencing: Company market share analysis, 2014
9. Next generation sequencing market share, by application, 2014 & 2022
10. Global HLA testing market, 2012 - 2022 (USD Billion)
11. Global prenatal testing market, 2012 - 2022 (USD Billion)
12. Global oncology market, 2012 - 2022 (USD Billion)
13. Global idiopathic diseases market, 2012 - 2022 (USD Billion)
14. Global infectious diseases market, 2012 - 2022 (USD Billion)
15. Next generation sequencing market share by technology, 2014 & 2022
16. Global whole genome sequencing market, 2012 - 2022 (USD Billion)
17. Global whole exon sequencing market, 2012 - 2022 (USD Billion)
18. Global panel sequencing & resequencig market, 2012 - 2022 (USD Billion)
19. Next generation sequencing market share by workflow, 2014 & 2022
20. Global NGS pre-sequencing market, 2012 - 2022 (USD Billion)
21. Global NGS sequencing market, 2012 - 2022 (USD Billion)
22. Global NGS data analysis market, 2012 - 2022 (USD Billion)
23. North America next generation sequencing market, 2012 - 2022 (USD Billion)
24. U.S. next generation sequencing market, 2012 - 2022 (USD Billion)
25. Canada next generation sequencing market, 2012 - 2022 (USD Billion)
26. Europe next generation sequencing market, 2012 - 2022 (USD Billion)
27. Germany next generation sequencing market, 2012 - 2022 (USD Billion)
28. UK next generation sequencing market, 2012 - 2022 (USD Billion)
29. Asia Pacific next generation sequencing market, 2012 - 2022 (USD Billion)
30. Japan next generation sequencing market, 2012 - 2022 (USD Billion)
31. China next generation sequencing market, 2012 - 2022 (USD Billion)
32. Latin America next generation sequencing market, 2012 - 2022 (USD Billion)
33. Brazil next generation sequencing market, 2012 - 2022 (USD Billion)
34. MEA next generation sequencing market, 2012 - 2022 (USD Billion)
35. South Africa next generation sequencing market, 2012 - 2022 (USD Billion)
1. Next Generation Sequencing: Market segmentation
2. Global next generation sequencing market, (USD Billion), 2012 - 2022
3. Next generation sequencing: Market dynamics
4. Next generation sequencing market - Porter’s Analysis
5. Key opportunities prioritized 2014
6. NGS Platform positioning
7. Next generation sequencing market - PESTEL analysis
8. Next generation sequencing: Company market share analysis, 2014
9. Next generation sequencing market share, by application, 2014 & 2022
10. Global HLA testing market, 2012 - 2022 (USD Billion)
11. Global prenatal testing market, 2012 - 2022 (USD Billion)
12. Global oncology market, 2012 - 2022 (USD Billion)
13. Global idiopathic diseases market, 2012 - 2022 (USD Billion)
14. Global infectious diseases market, 2012 - 2022 (USD Billion)
15. Next generation sequencing market share by technology, 2014 & 2022
16. Global whole genome sequencing market, 2012 - 2022 (USD Billion)
17. Global whole exon sequencing market, 2012 - 2022 (USD Billion)
18. Global panel sequencing & resequencig market, 2012 - 2022 (USD Billion)
19. Next generation sequencing market share by workflow, 2014 & 2022
20. Global NGS pre-sequencing market, 2012 - 2022 (USD Billion)
21. Global NGS sequencing market, 2012 - 2022 (USD Billion)
22. Global NGS data analysis market, 2012 - 2022 (USD Billion)
23. North America next generation sequencing market, 2012 - 2022 (USD Billion)
24. U.S. next generation sequencing market, 2012 - 2022 (USD Billion)
25. Canada next generation sequencing market, 2012 - 2022 (USD Billion)
26. Europe next generation sequencing market, 2012 - 2022 (USD Billion)
27. Germany next generation sequencing market, 2012 - 2022 (USD Billion)
28. UK next generation sequencing market, 2012 - 2022 (USD Billion)
29. Asia Pacific next generation sequencing market, 2012 - 2022 (USD Billion)
30. Japan next generation sequencing market, 2012 - 2022 (USD Billion)
31. China next generation sequencing market, 2012 - 2022 (USD Billion)
32. Latin America next generation sequencing market, 2012 - 2022 (USD Billion)
33. Brazil next generation sequencing market, 2012 - 2022 (USD Billion)
34. MEA next generation sequencing market, 2012 - 2022 (USD Billion)
35. South Africa next generation sequencing market, 2012 - 2022 (USD Billion)
